Distinguished Faculty:

John L. Allinson, FIBMS, Director, Veeda Clinical Research Ltd.

Miriam Bayes, Ph.D., Head Scientific & Content Development, Thomson Scientific

Jens Beator, Ph.D., Director, Protein Biochips, Protagen AG

Christine Betard, Ph.D., Senior Director, Global Strategic Drug Development Unit, Quntiles

Michael E. Burczynski, Ph.D., Associate Director, Biomarker Laboratory, Clinical Translational Medicine, Wyeth Research

Raffaella Castoldi, M.S., Head of Analytical Biology, DMPK, Accelera/Nerviano Medical Sciences

Daniel Chelsky, Ph.D., Chief Scientific Officer, Caprion Proteomics

Tao Chen, Ph.D., Research Toxicologist, Division of Genetic and Reproductive Toxicology, FDA/NCTR

Viswanath Devanarayan, Ph.D., Director, Statistics, Biomarker Research, Abbott Laboratories

Enrico Domenici, Ph.D., Director, Molecular Psychiatry, GSK Medicines Research Centre

Nicholas C. Dracopoli, Ph.D., Vice President, Biomarkers, Centocor R&D, Johnson & Johnson

Darius Dziuda, Ph.D., Assistant Professor, Mathematical Sciences, Central Connecticut State University

Dave Englert, Ph.D., Vice President, Technology Development, Xceed Molecular

Andreas Freidig, Ph.D., Senior Scientist, BU Biosciences, TNO, Quality of Life

Herbert A. Fritsche, Ph.D., Professor and Chief of Clinical Chemistry, The University of Texas M. D. Anderson Cancer Center

Philip M. Hemken, Ph.D., Principle Scientist, Cancer Research Diagnostics, Abbott Laboratories

Yiwu He, Ph.D., MBA, Senior Program Officer, Global Health, The Bill &Melinda Gates Foundation

Debra A. Hope, Ph.D., MBA, Director, Business Development, Theranostics Health

Joanna Hunter, Ph.D., Director, Protein Analysis, Caprion Proteomics Inc.

Gordon F. Kapke, Ph.D., Senior Director, Biomarker Services, Covance Central Laboratory Services

Clare Kingsley, Ph.D., Client Manager, Biomarkers, HFL Ltd.

Geert Kolvenbag, M.D., Ph.D., Executive Director, Development, Emerging Oncology and Infection Brands, AstraZeneca

Rajesh Krishnan, Ph.D., Director, Business Development and Strategic Alliances, Pathway Diagnostics

Mark R. Lackner, Ph.D., Scientist, Development Oncology Diagnostics, Genentech Inc.

Ole Lagatie, Ph.D., Scientific Advisor, Bioanalysis, Eurofins Medinet

Eric Lai, Ph.D., Vice President, Pharmacogenetics Experimental Project Coordination and Analysis, GlaxoSmithKline

Michael N. Liebman, Ph.D., Senior Institute Fellow, Windber Research Institute

Cathy Lofton-Day, Ph.D., Vice President, Molecular Biology, Diagnostics, Epigenomics, Inc.

Peter Maimonis, Ph.D., Vice President, Biological Research, Decision Biomarkers Inc.

Elizabeth Mansfield, Ph.D., Senior Policy Analyst, Office of Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiologic Health, US Food and Drug Administration

Shawnmarie Mayrand-Chung, Ph.D., J.D., NIH Program Director, The Biomarkers Consortium; Public-Private Partnership Program, Office of Science Policy, Office of the Director, National Institutes of Health

Søren Møller, Ph.D., Chief Scientific Officer, Vice President, R&D, Exiqon A/S

Nagaraja Muniappa, Ph.D., DVM, Senior Investigator, Pathology, Safety Assessment, Merck Research Laboratories

Art Okamoto, Ph.D., Senior Product Manager, Ingenuity Pathways Analysis, Ingenuity Systems

Scott D. Patterson, Ph.D., Executive Director, Medical Sciences, Amgen Inc.

Paul H. Pevsner, M.D., Research Associate Professor of Pharmacology, New York University School of Medicine

J. Suso Platero, Ph.D., Associate Director, Clinical Biomarkers, Discovery Medicine and Clinical Pharmacology, Bristol-Myers Squibb Co.

Steven J. Potts, Ph.D., MBA, Scientific Director, Biotechnology and Pharmaceutical, Aperio Technologies

Uma Prabhakar, Ph.D., Senior Director, Biomarkers, Centocor Inc.

Mitch Raponi, Ph.D., Principal Research Scientist, Biomarkers and Translational Research, Centocor Research & Development

Paul Rhyne, Ph.D., Associate Director, Bioanalytical Sciences, Research and Development, Bristol-Myers Squibb Co.

Michael Samoszuk, M.D., Chief Medical Officer, Roche Diagnostics Corp.

Peter Schulz-Knappe, Ph.D., Chief Scientific Officer, Proteome Sciences plc

Andreas Schuppert, Ph.D., Director, Applied Sciences, Bayer Technology Services GmbH

Martin Shaw, Senior Scientific Officer, Biotrin International

Adam J. Simon, Ph.D., Senior Research Fellow, Biomarkers, Integrative Systems Neuroscience, Merck Research Laboratories

Keld Sorensen, Ph.D., Director, Research & Development, Luminex Bioscience Group

Thomas F. Soriano, President and Chief Executive Officer, DOCRO, Inc.

Philip Stegmaier, Research Scientist, Research & Development, BIOBASE GmbH

Michael Stocum, Managing Director, Personalized Medicine Partners

Anna E. Szafranska, Ph.D., Senior Scientist, Asuragen Inc.

Stephen Tahir, Ph.D., Research Investigator, Cancer, Abbott Laboratories

Patrick Terry, Co-founder, Director of Industry Relations, Genomic Health, Inc.

David C. Thompson, Ph.D., Research Fellow, Drug Safety Research & Development, Pfizer Inc.

Miro Venturi, Ph.D., Novartis Biologics

Katerina Vlasakova, Research Associate, Systems Toxicology, Safety Assessment, Merck Research Laboratories

John A. Wagner, M.D., Ph.D., Executive Director, Clinical Pharmacology, Merck Research Laboratories

Elizabeth Gribble Walker, Ph.D., Assistant Director, Toxicology, Predictive Safety Testing Consortium, Critical Path Institute

Yixin Wang, Ph.D., Executive Director, Research & Development, Veridex, LLC., a Johnson & Johnson Company

Jeffrey F. Waring, Ph.D., Associate Research Fellow, Group Leader, Abbott Laboratories

Thomas J. White, Ph.D., Chief Scientific Officer, Celera

Mark Wilkinson, Ph.D., Assistant Professor, Medical Genetics and Bioinformatics, James Hogg iCAPTURE Centre

Mark Wing, Ph.D., Director, Clinical and Translational Sciences

Alan H.B. Wu, Ph.D., Professor, Department of Laboratory Medicine, Director, Clinical Chemistry, Toxicology and Pharmacogenomics Laboratories, University of California, San Francisco

Yan J. Zhang, Ph.D., Senior Research Investigator, Clinical Biomarker Development, Bioanalytical Science, Bristol-Myers Squibb Co.